Invesco Ltd. Palatin Technologies Inc Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.41 - $0.73 $5,980 - $10,648	-14,587 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $16,251 - $35,663	-45,144 Reduced 75.58%	14,587 $6,000
Q4 2019 Feb 14, 2020	BUY	$0.75 - $0.89 $34,377 - $40,794	45,837 Added 329.9%	59,731 $47,000
Q3 2019 Nov 14, 2019	BUY	$0.78 - $1.09 $10,837 - $15,144	13,894 New	13,894 $13,000
Q1 2019 May 15, 2019	SELL	$0.67 - $1.01 $36,391 - $54,858	-54,315 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.0 $34,218 - $54,315	54,315 New	54,315 $38,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.3M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.